par D'Hondt, Veronique 
;Gil, Thierry ;Lalami, Yassine ;Piccart-Gebhart, Martine ;Awada, Ahmad
Référence European journal of cancer, 41, 9, page (1246-1253)
Publication Publié, 2005-06
;Gil, Thierry ;Lalami, Yassine ;Piccart-Gebhart, Martine ;Awada, Ahmad Référence European journal of cancer, 41, 9, page (1246-1253)
Publication Publié, 2005-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | D'Hondt, Veronique; Gil, Thierry; Lalami, Yassine; Piccart-Gebhart, Martine; Awada, Ahmad |
| Informations sur la publication: | European journal of cancer, 41, 9, page (1246-1253) |
| Statut de publication: | Publié, 2005-06 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Anti-angiogenesis agents |
| Molecular-targeted therapy | |
| New drugs | |
| Renal cell carcinoma | |
| Review | |
| MeSH keywords: | Angiogenesis Inhibitors -- therapeutic use |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Carcinoma, Renal Cell -- drug therapy | |
| Clinical Trials as Topic | |
| Humans | |
| Immunotherapy -- methods | |
| Kidney Neoplasms -- drug therapy | |
| Receptors, Growth Factor -- antagonists & inhibitors | |
| Signal Transduction -- drug effects | |
| Treatment Outcome | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0959-8049 |
| info:doi/10.1016/j.ejca.2004.11.025 | |
| info:pii/S0959-8049(05)00186-3 | |
| info:scp/19444380679 | |
| info:pmid/15939260 |
